Home Search
cannpal - search results
If you're not happy with the results, please do another search
AusCann To Acquire CannPal
Australian medical cannabis company AusCann (ASX:AC8) has announced its intention to acquire CannPal Animal Therapeutics (ASX:CP1).
After emerging from a trading halt that began last...
CannPal Granted Licence For CSIRO MicroMAX Tech
Australian animal therapeutics company CannPal (ASX:CP1) has been granted an exclusive global licence to use technology developed by Australia's national science research agency for...
CannPal Progressing Canine Cannabinoid Trials
Australia’s CannPal Animal Therapeutics Limited (ASX:CP1) has announced it has commenced its Phase 2A pilot dose determination study for its canine osteoarthritis treatment, CPAT-01,...
CannPal Teams Up With University Of Melbourne On Canine Epilepsy Research
Australia's CannPal Animal Therapeutics Limited (ASX:CP1) has inked an agreement with the University of Melbourne relating to research on the efficacy of cannabidiol in...
Cannpal Canine Cannabis Clinical Trial To Commence This Week
Australian company CannPal Animal Therapeutics Limited (ASX:CP1) has announced it has received the first import of its first medical cannabis oil formulation, and dosing...
Australia’s CannPal Gets Approval For Canine Cannabinoid Trial
CannPal Animal Therapeutics Limited (ASX:CP1) has announced it has received ethics approval for a large pharmacokinetic and safety study in dogs involving THC and...
Dermacann For Dogs Reaches Final Hurdle In Australia
Australia's AusCann (ASX:AC8) announced last week it has submitted final regulatory paperwork required to get the company's cannabis based canine skin and dermatitis treatment...
Michigan Veterinarians Can Now Talk About CBD
A bill signed into law by Michigan Governor Gretchen Whitmer last week enables veterinarians in the state to discuss cannabis treatments with pet owners.
Prior...
Cannabis Showing Promise For Treating Dermatitis In Dogs
A cannabis-based formulation developed by Australia's CannPal (ASX:CP1) has substantially reduced atopic dermatitis severity in dogs participating in clinical trial.
Atopic dermatitis is triggered by...
Creso Pharma Carves It Up With Cannabidiol For Canines
Creso Pharma Limited (ASX:CPH) announced yesterday it has sold more than 3 million doses of its cannabidiol based product designed for dogs.
The major milestone...
Advertisement
